Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas. (Q40385211)
Jump to navigation
Jump to search
scientific article published on October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas. |
scientific article published on October 2005 |
Statements
Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas (English)
David R D'Adamo
Sibyl E Anderson
Karen Albritton
Jennifer Yamada
Elyn Riedel
Kelly Scheu
Gary K Schwartz
1 October 2005